Face-to-Face Meetings
- Edmonton, November 2, 2006 (Westin Edmonton)
- Montréal, November 8, 2006 (Château Champlain)
- Toronto, November 16, 2006 (Sheraton Centre)
- Halifax, November 28, 2006 (Westin Nova Scotia)
- Ottawa, November 30, 2006 (Château Cartier)
EDMONTON - November 2 - (Westin Edmonton)
Edmonton
November 2, 2006
(8:30am - 4:30pm)
The Westin Edmonton
10135-100th Street
Edmonton AB B3H 2P6
Agenda (PDF)
The Board is looking forward to meeting stakeholders at its face-to-face meetings throughout the month of November. The Board also wishes to take this opportunity to thank the invited stakeholders who have already confirmed their participation.
The November meetings are the third stage in a process the Board is undertaking to review and obtain feedback from stakeholders on various aspects of its current Excessive Price Guidelines. The first event was the release of a Discussion Paper on Drug Price Increases in March 2005, which was then followed by the publication, in May 2006, of a Discussion Guide for the Consultations on the Board's Excessive Price Guidelines.
The main objective of the upcoming meetings is to foster open discussion among different stakeholder groups on certain aspects of the regulatory role of the PMPRB and its Guidelines on Excessive Prices.
The meetings will start at 8:30 a.m. and adjourn no later than 4:30 p.m.
A Board member will be present at each meeting. The agenda will consist of short presentations by Staff followed by small group breakout sessions on three themes:
- overall principles that should underpin the Board's interpretation of its mandate in the Patent Act;
- further discussion of What We Heard on the issues raised in the Discussion Guide; and
- whether and on what grounds the PMPRB should conduct a re-review of the excessiveness of a drug price. Facilitators will assist the participants in working through the small group discussions. Staff of the PMPRB will also be on hand to answer any questions about the current Guidelines. Following each breakout session, a summary of the discussion will be reported back in plenary.
Reports on the highlights of each November consultation meeting, as well as a summary of all five meetings, will be produced and posted on the PMPRB's Web site in early 2007. Further steps in the Board's process of review and consultation on its Guidelines will be communicated through future NEWSletters.
If you have any further questions on the Consultations, please contact us at pmprb@pmprb-cepmb.gc.ca
Reference Documents:
MONTRÉAL - November 8 - (Château Champlain)
Montréal
November 8, 2006
(8:30am - 4:30pm)
Montréal Marriott Château Champlain
1050 de la Gauchetière West
Montréal QC H3B 4C9
Agenda (PDF)
The Board is looking forward to meeting stakeholders at its face-to-face meetings throughout the month of November. The Board also wishes to take this opportunity to thank the invited stakeholders who have already confirmed their participation.
The November meetings are the third stage in a process the Board is undertaking to review and obtain feedback from stakeholders on various aspects of its current Excessive Price Guidelines. The first event was the release of a Discussion Paper on Drug Price Increases in March 2005, which was then followed by the publication, in May 2006, of a Discussion Guide for the Consultations on the Board's Excessive Price Guidelines.
The main objective of the upcoming meetings is to foster open discussion among different stakeholder groups on certain aspects of the regulatory role of the PMPRB and its Guidelines on Excessive Prices.
The meetings will start at 8:30 a.m. and adjourn no later than 4:30 p.m.
A Board member will be present at each meeting. The agenda will consist of short presentations by Staff followed by small group breakout sessions on three themes:
- overall principles that should underpin the Board's interpretation of its mandate in the Patent Act;
- further discussion of What We Heard on the issues raised in the Discussion Guide; and
- whether and on what grounds the PMPRB should conduct a re-review of the excessiveness of a drug price. Facilitators will assist the participants in working through the small group discussions. Staff of the PMPRB will also be on hand to answer any questions about the current Guidelines. Following each breakout session, a summary of the discussion will be reported back in plenary.
Reports on the highlights of each November consultation meeting, as well as a summary of all five meetings, will be produced and posted on the PMPRB's Web site in early 2007. Further steps in the Board's process of review and consultation on its Guidelines will be communicated through future NEWSletters.
If you have any further questions on the Consultations, please contact us at pmprb@pmprb-cepmb.gc.ca
Reference Documents:
TORONTO - November 16 - (Sheraton Centre)
Toronto
November 16, 2006
(8:30 am - 4:30pm)
Sheraton Centre Toronto
123 Queen Street West
Toronto ON M5H 2M9
Agenda (PDF)
The Board is looking forward to meeting stakeholders at its face-to-face meetings throughout the month of November. The Board also wishes to take this opportunity to thank the invited stakeholders who have already confirmed their participation.
The November meetings are the third stage in a process the Board is undertaking to review and obtain feedback from stakeholders on various aspects of its current Excessive Price Guidelines. The first event was the release of a Discussion Paper on Drug Price Increases in March 2005, which was then followed by the publication, in May 2006, of a Discussion Guide for the Consultations on the Board's Excessive Price Guidelines.
The main objective of the upcoming meetings is to foster open discussion among different stakeholder groups on certain aspects of the regulatory role of the PMPRB and its Guidelines on Excessive Prices.
The meetings will start at 8:30 a.m. and adjourn no later than 4:30 p.m.
A Board member will be present at each meeting. The agenda will consist of short presentations by Staff followed by small group breakout sessions on three themes:
- overall principles that should underpin the Board's interpretation of its mandate in the Patent Act;
- further discussion of What We Heard on the issues raised in the Discussion Guide; and
- whether and on what grounds the PMPRB should conduct a re-review of the excessiveness of a drug price. Facilitators will assist the participants in working through the small group discussions. Staff of the PMPRB will also be on hand to answer any questions about the current Guidelines. Following each breakout session, a summary of the discussion will be reported back in plenary.
Reports on the highlights of each November consultation meeting, as well as a summary of all five meetings, will be produced and posted on the PMPRB's Web site in early 2007. Further steps in the Board's process of review and consultation on its Guidelines will be communicated through future NEWSletters.
If you have any further questions on the Consultations, please contact us at pmprb@pmprb-cepmb.gc.ca
Reference Documents:
HALIFAX - November 28 - (Westin Nova Scotia)
Halifax
November 28, 2006
(8:30am - 4:30pm)
The Westin Nova Scotian
1181 Hollis Street
Halifax NS B3H 2P6
Agenda (PDF)
The Board is looking forward to meeting stakeholders at its face-to-face meetings throughout the month of November. The Board also wishes to take this opportunity to thank the invited stakeholders who have already confirmed their participation.
The November meetings are the third stage in a process the Board is undertaking to review and obtain feedback from stakeholders on various aspects of its current Excessive Price Guidelines. The first event was the release of a Discussion Paper on Drug Price Increases in March 2005, which was then followed by the publication, in May 2006, of a Discussion Guide for the Consultations on the Board's Excessive Price Guidelines.
The main objective of the upcoming meetings is to foster open discussion among different stakeholder groups on certain aspects of the regulatory role of the PMPRB and its Guidelines on Excessive Prices.
The meetings will start at 8:30 a.m. and adjourn no later than 4:30 p.m.
A Board member will be present at each meeting. The agenda will consist of short presentations by Staff followed by small group breakout sessions on three themes:
- overall principles that should underpin the Board's interpretation of its mandate in the Patent Act;
- further discussion of What We Heard on the issues raised in the Discussion Guide; and
- whether and on what grounds the PMPRB should conduct a re-review of the excessiveness of a drug price. Facilitators will assist the participants in working through the small group discussions. Staff of the PMPRB will also be on hand to answer any questions about the current Guidelines. Following each breakout session, a summary of the discussion will be reported back in plenary.
Reports on the highlights of each November consultation meeting, as well as a summary of all five meetings, will be produced and posted on the PMPRB's Web site in early 2007. Further steps in the Board's process of review and consultation on its Guidelines will be communicated through future NEWSletters.
If you have any further questions on the Consultations, please contact us at pmprb@pmprb-cepmb.gc.ca
Reference Documents:
OTTAWA - November 30 - (Château Cartier)
Ottawa
November 30, 2006
(8:30am - 4:30pm)
Château Cartier
1170, Chemin Aylmer
Gatineau QC J9H 5E1
Agenda (PDF)
The Board is looking forward to meeting stakeholders at its face-to-face meetings throughout the month of November. The Board also wishes to take this opportunity to thank the invited stakeholders who have already confirmed their participation.
The November meetings are the third stage in a process the Board is undertaking to review and obtain feedback from stakeholders on various aspects of its current Excessive Price Guidelines. The first event was the release of a Discussion Paper on Drug Price Increases in March 2005, which was then followed by the publication, in May 2006, of a Discussion Guide for the Consultations on the Board's Excessive Price Guidelines.
The main objective of the upcoming meetings is to foster open discussion among different stakeholder groups on certain aspects of the regulatory role of the PMPRB and its Guidelines on Excessive Prices.
The meetings will start at 8:30 a.m. and adjourn no later than 4:30 p.m.
A Board member will be present at each meeting. The agenda will consist of short presentations by Staff followed by small group breakout sessions on three themes:
- overall principles that should underpin the Board's interpretation of its mandate in the Patent Act;
- further discussion of What We Heard on the issues raised in the Discussion Guide; and
- whether and on what grounds the PMPRB should conduct a re-review of the excessiveness of a drug price. Facilitators will assist the participants in working through the small group discussions. Staff of the PMPRB will also be on hand to answer any questions about the current Guidelines. Following each breakout session, a summary of the discussion will be reported back in plenary.
Reports on the highlights of each November consultation meeting, as well as a summary of all five meetings, will be produced and posted on the PMPRB's Web site in early 2007. Further steps in the Board's process of review and consultation on its Guidelines will be communicated through future NEWSletters.
If you have any further questions on the Consultations, please contact us at pmprb@pmprb-cepmb.gc.ca
Reference Documents: